Vaxidrug Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 1.00 M
as on 11-07-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 11-07-2024
- Revenue 40.98%
(FY 2022)
- Profit 45.36%
(FY 2022)
- Ebitda 125.51%
(FY 2022)
- Net Worth 33.27%
(FY 2022)
- Total Assets 27.98%
(FY 2022)
About Vaxidrug Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 Cr.
Mannaseril Amarnishanth, Prakash Abhilash, and Damodaran Prakash serve as directors at the Company.
- CIN/LLPIN
U51397TZ2014PTC020769
- Company No.
020769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaxidrug Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mannaseril Amarnishanth  | Managing Director | 24-Sep-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Abhilash | Director | 24-Sep-2014 | Current |
| Damodaran Prakash | Director | 24-Sep-2014 | Current |
Financial Performance of Vaxidrug Pharmaceuticals.
Vaxidrug Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.98% increase. The company also saw a substantial improvement in profitability, with a 45.36% increase in profit. The company's net worth Soared by an impressive increase of 33.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaxidrug Pharmaceuticals?
In 2021, Vaxidrug Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaximed Private LimitedActive 1 year 7 monthsMannaseril Amarnishanth and Prakash Abhilash are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Vaxidrug Pharmaceuticals?
Unlock and access historical data on people associated with Vaxidrug Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaxidrug Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxidrug Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
